T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survival
about
The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-AnalysisClinical significance of tumor-infiltrating lymphocytes in breast cancerPrognostic significance of tumor infiltrating immune cells in oral squamous cell carcinomaA feasibility study of cyclophosphamide, trastuzumab, and an allogeneic GM-CSF-secreting breast tumor vaccine for HER2+ metastatic breast cancer.A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumorsT-box transcription factor 21 expression in breast cancer and its relationship with prognosis.Impaired T-bet-pSTAT1α and perforin-mediated immune responses in the tumoral region of lung adenocarcinoma.Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body RadiotherapyTumoral lymphocytic infiltration and expression of the chemokine CXCL10 in breast cancers from the Ontario Familial Breast Cancer RegistryCan pharmacological receptor tyrosine kinase inhibitors sensitize poor outcome breast tumors to immune-based therapies?PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas.Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade.Trastuzumab upregulates expression of HLA-ABC and T cell costimulatory molecules through engagement of natural killer cells and stimulation of IFNγ secretion.Noncanonical roles of the immune system in eliciting oncogene addictionCan immunity to breast cancer eliminate residual micrometastases?Tumor-infiltrating lymphocytes predict prognosis of breast cancer patients treated with anti-Her-2 therapyCombining immunotherapy and targeted therapies in cancer treatment.The split nature of tumor-infiltrating leukocytes: Implications for cancer surveillance and immunotherapy.Targeting antitumor CD4 helper T cells with universal tumor-reactive helper peptides derived from telomerase for cancer vaccine.New protein kinase inhibitors in breast cancer: afatinib and neratinib.A Comparative Approach of Tumor-Associated Inflammation in Mammary Cancer between Humans and Dogs.Toward integrative cancer immunotherapy: targeting the tumor microenvironment.Association between the genetic variations within TBX21 gene promoter and the clinicopathological characteristics of esophageal squamous cell carcinoma in a high-risk Chinese population.Trastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFNγ secretion.
P2860
Q26748691-B93B47C8-A65F-42F3-B07F-E33E730CF7B6Q28070214-D61EA1F2-483A-4F45-B487-93EA962AAB85Q33733725-996FA1C7-7605-40B1-B8F3-59B7B6B31273Q34412289-6BDB8766-352F-4A4B-8ACC-5DB9153723CDQ34483473-82BCE056-8A9E-474E-B711-2006BB120F03Q34502054-67A5EB8E-11B4-44D8-862D-ECAC9B04DAD4Q36081360-254A465D-B658-438B-A511-55BF5A8A1F21Q36483105-7E210714-5B25-46A2-81CA-3DBF491B48E6Q36544876-A189E74B-6655-41DE-9F2F-6331A5239E58Q36605526-3A0AEEA9-4284-4A03-8A5A-0431FB584140Q36652112-2DFDB09F-4048-46D9-9336-F6F2DD28DEBEQ36653524-51AE24D0-CB93-485D-AEDA-9191F973FE40Q36821168-33B8E579-981B-410E-B387-39992DD4CDB7Q36931816-F4AD6502-1F9D-441C-ACCB-7D798170AB0EQ37396270-3BCCE923-00AC-47EF-A57E-F18C2A47EBE9Q37706331-BF015624-5997-4857-BBA6-518D51766E1AQ37995939-0AE78E8E-6600-4903-AE52-E9C396E98556Q38039112-787E6949-6CA9-4961-AF33-FECECD9EE922Q38077405-BFD4BA92-87DE-4C9D-A4CC-AAD0DBA629ABQ39200319-BA3DD000-AFC4-4113-8484-BA9A0C3F7AAAQ42344612-65CF5DBE-D473-4D21-8456-CCD7A0426400Q43158322-E45608B1-78FF-47EB-A328-F04C784C9E15Q53647584-52D675EE-0609-4BE2-942C-4B6D2969F458Q54979386-7DE53E30-C2CF-4D44-AAE4-6B439DA8D9CA
P2860
T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survival
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
T-bet expression in intratumor ...... st carcinoma predicts survival
@ast
T-bet expression in intratumor ...... st carcinoma predicts survival
@en
type
label
T-bet expression in intratumor ...... st carcinoma predicts survival
@ast
T-bet expression in intratumor ...... st carcinoma predicts survival
@en
prefLabel
T-bet expression in intratumor ...... st carcinoma predicts survival
@ast
T-bet expression in intratumor ...... st carcinoma predicts survival
@en
P2093
P2860
P50
P356
P1476
T-bet expression in intratumor ...... st carcinoma predicts survival
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.2011.261
P407
P577
2011-07-12T00:00:00Z